Patents by Inventor Daniel Vallera

Daniel Vallera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REDUCTION OF EGFR THERAPEUTIC TOXICITY
    Publication number: 20190388521
    Abstract: In certain embodiments, the present invention provides a method of treating a subject having a tumor that expresses EGFR and/or uPAR, even if at low levels. In certain embodiments, the present invention provides a method of preventing hemangiosarcoma (HSA) in a dog predisposed to developing HSA or angiosarcoma in a human predisposed to developing angiosarcoma. In certain embodiments, the present invention provides a method of preventing a hemangiosarcoma (HSA) in a dog that is positive for HSA by means of a blood test but negative by tumor imaging.
    Type: Application
    Filed: May 6, 2019
    Publication date: December 26, 2019
    Inventors: Jaime F. Modiano, Daniel Vallera, Antonella Borgatti
  • REDUCTION OF EGFR THERAPEUTIC TOXICITY
    Publication number: 20170106059
    Abstract: In certain embodiments, the present invention provides a method of treating a subject having a tumor that expresses EGFR and/or uPAR, even if at low levels. In certain embodiments, the present invention provides a method of preventing hemangiosarcoma (HSA) in a dog predisposed to developing HSA or angiosarcoma in a human predisposed to developing angiosarcoma. In certain embodiments, the present invention provides a method of preventing a hemangiosarcoma (HSA) in a dog that is positive for HSA by means of a blood test but negative by tumor imaging.
    Type: Application
    Filed: September 29, 2016
    Publication date: April 20, 2017
    Applicant: REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Jaime F. Modiano, Daniel Vallera, Antonella Borgatti
  • DTAT fusion toxin
    Publication number: 20050245448
    Abstract: The invention provides fusion toxins that contain one or more regions of diphtheria toxin and a portion of urokinase-type plasminogen activator, as well as the nucleic acids that encode the fusion toxins and methods of using the fusion toxins.
    Type: Application
    Filed: January 18, 2005
    Publication date: November 3, 2005
    Inventors: Daniel Vallera, Walter Hall